Bulletin
Investor Alert

Inovalon Holdings Inc. Cl A

NAS: INOV

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Apr 2, 2020, 4:02 p.m.

/zigman2/quotes/201325530/composite

$

16.33

Change

+0.39 +2.45%

Volume

Volume 4,818

Quotes are delayed by 20 min

/zigman2/quotes/201325530/composite

Today's close

$ 16.09

$ 15.94

Change

-0.15 -0.93%

Day low

Day high

$15.36

$16.14

Open

52 week low

52 week high

$11.50

$22.99

Open

Insider Actions for Inovalon Holdings Inc. Cl A

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/15/2020 Jason B. Capitel
Chief Operating Officer
4,451   Derivative/Non-derivative trans. at $17.11 per share. 76,156
03/15/2020 Robert A. Wychulis
President
4,127   Derivative/Non-derivative trans. at $17.11 per share. 70,612
03/15/2020 Robert A. Wychulis
President
1,528   Derivative/Non-derivative trans. at $17.11 per share. 26,144
03/15/2020 Jonathan R. Boldt
Chief Financial Officer
1,045   Derivative/Non-derivative trans. at $17.11 per share. 17,879
03/15/2020 Jonathan R. Boldt
Chief Financial Officer
4,586   Derivative/Non-derivative trans. at $17.11 per share. 78,466
03/15/2020 Jonathan R. Boldt
Chief Financial Officer
1,526   Derivative/Non-derivative trans. at $17.11 per share. 26,109
03/02/2020 Robert A. Wychulis
President
5,961   Derivative/Non-derivative trans. at $19.96 per share. 118,981
03/02/2020 Jonathan R. Boldt
Chief Financial Officer
1,363   Derivative/Non-derivative trans. at $19.96 per share. 27,205
02/29/2020 Jason B. Capitel
Chief Operating Officer
453   Award at $16.56 per share. 7,501
02/25/2020 Jason B. Capitel
Chief Operating Officer
21,240   Derivative/Non-derivative trans. at $22.27 per share. 473,014
02/25/2020 Robert A. Wychulis
President
310,078   0
02/25/2020 Keith R. Dunleavy
CEO and Chairman of the Board; Director
32,934   Acquisition at $20.08 per share. 661,314
02/25/2020 Robert A. Wychulis
President
863   Derivative/Non-derivative trans. at $19.57 per share. 16,888
02/24/2020 Keith R. Dunleavy
CEO and Chairman of the Board; Director
30,071   Acquisition at $20.61 per share. 619,763
02/14/2020 Jonathan R. Boldt
Chief Financial Officer
10,788   Derivative/Non-derivative trans. at $22.02 per share. 237,551
02/14/2020 Peter De Bock
Chief Administrative Officer
9,910   Derivative/Non-derivative trans. at $22.02 per share. 218,218
02/14/2020 Isaac Kohane
Director
12,307   Derivative/Non-derivative trans. at $0 per share. 0
02/13/2020 Jason B. Capitel
Chief Operating Officer
34,169   Award at $0 per share. 0
02/13/2020 Robert A. Wychulis
President
16,572   Award at $0 per share. 0
02/13/2020 Robert A. Wychulis
President
33,144   Award at $0 per share. 0
02/13/2020 Jonathan R. Boldt
Chief Financial Officer
4,072   Award at $0 per share. 0
02/13/2020 Jonathan R. Boldt
Chief Financial Officer
17,916   Award at $0 per share. 0
02/13/2020 Peter De Bock
Chief Administrative Officer
3,837   Award at $0 per share. 0
02/13/2020 Peter De Bock
Chief Administrative Officer
16,879   Award at $0 per share. 0
02/08/2020 Jason B. Capitel
Chief Operating Officer
19,961   Derivative/Non-derivative trans. at $0 per share. 0
11/16/2019 Mike M. Burgin
Chief Product Officer
3,203   Derivative/Non-derivative trans. at $17.32 per share. 55,475
11/12/2019 Mike M. Burgin
Chief Product Officer
5,768   Derivative/Non-derivative trans. at $16.91 per share. 97,536

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
12 Purchases
13 Sales
203,217
396,564
Last 6 months
12 Purchases
17 Sales
203,217
410,321
Last 12 months
24 Purchases
19 Sales
462,475
420,640

Officers and Executives

Dr. Keith R. Dunleavy
Chairman & Chief Executive Officer
Mr. Robert A. Wychulis
President
Mr. Jason B. Capitel
Chief Operating Officer
Mr. Jonathan R. Boldt
Chief Financial & Accounting Officer
Mr. Peter De Bock
Chief Administrative Officer
Dr. Kathryn Eshelman
VP-Clinical Informatics & Enterprise Solutions
Mr. Eric Sullivan
Senior Vice President-Innovation & Data Strategies
Mr. Mike M. Burgin
Chief Product Officer
Mr. Mark A. Pulido
Director
Dr. Isaac Kohane
Director
Ms. Kim E. Collins
Senior VP-Marketing & Communications
Mr. George A. Price
Head-Investor Relations
Ms. Ingrid E. Olsen
Ms. Denise K. Fletcher
Independent Director
Mr. André S. Hoffmann
Independent Director
Mr. Lee D. Roberts
Independent Director
Mr. William J. Teuber
Independent Director
Mr. William D. Green
Independent Director
Link to MarketWatch's Slice.